Ankylosing spondylitis: an overview

J Sieper, J Braun, M Rudwaleit, A Boonen… - Annals of the rheumatic …, 2002 - ard.bmj.com
Ankylosing spondylitis (AS) is a complex, potentially debilitating disease that is insidious in
onset, progressing to radiological sacroiliitis over several years. Patients with symptomatic …

[HTML][HTML] Nutrition interventions in rheumatoid arthritis: the potential use of plant-based diets. A review

J Alwarith, H Kahleova, E Rembert, W Yonas… - Frontiers in …, 2019 - frontiersin.org
Rheumatoid arthritis (RA), a chronic inflammatory autoimmune disease, affects roughly 1%
of the world's population. RA pathogenesis remains unclear, but genetic factors account for …

The gut microbiome in psoriasis and psoriatic arthritis

B Myers, N Brownstone, V Reddy, S Chan… - Best Practice & …, 2019 - Elsevier
This review summarizes existing research on the gut microbiome composition and function
in psoriasis and psoriatic arthritis, exploring potential roles in disease pathogenesis …

Six‐month results of a double‐blind, placebo‐controlled trial of etanercept treatment in patients with active ankylosing spondylitis

J Brandt, A Khariouzov, J Listing… - … : Official Journal of …, 2003 - Wiley Online Library
Objective There is increasing evidence that tumor necrosis factor α (TNFα) is centrally
involved in the pathogenesis of ankylosing spondylitis (AS) and other spondylarthritides …

Successful treatment of active ankylosing spondylitis with the anti–tumor necrosis factor α monoclonal antibody infliximab

J Brandt, H Haibel, D Cornely, W Golder… - … : Official Journal of …, 2000 - Wiley Online Library
Objective Tumor necrosis factor α (TNFα) has been detected in sacroiliac joint biopsy
specimens from patients with spondylarthropathy. The present open pilot study was …

Extraintestinal manifestations of inflammatory bowel disease

CG Su, TA Judge, GR Lichtenstein - Gastroenterology Clinics, 2002 - gastro.theclinics.com
Extraintestinal manifestations occur in 21% to 36% of patients with inflammatory bowel
disease (IBD)[37, 50, 90,105,128]. A wide variety of disorders involving virtually every organ …

HLA-B27-associated reactive arthritis: pathogenetic and clinical considerations

I Colmegna, R Cuchacovich… - Clinical microbiology …, 2004 - Am Soc Microbiol
Current evidence supports the concept that reactive arthritis (ReA) is an immune-mediated
synovitis resulting from slow bacterial infections and showing intra-articular persistence of …

Prevalence of ankylosing spondylitis and other spondyloarthropathies among patients with inflammatory bowel disease: a population study (the IBSEN study).

O Palm, B Moum, A Ongre, JT Gran - The Journal of rheumatology, 2002 - jrheum.org
OBJECTIVE: To study the occurrence of spondyloarthropathies (SpA) in patients with
inflammatory bowel disease (IBD) seen 6 years after IBD diagnosis. METHODS: In a …

Effects of a very low-fat, vegan diet in subjects with rheumatoid arthritis

J McDougall, B Bruce, G Spiller… - The Journal of …, 2002 - liebertpub.com
Objective: To demonstrate the effects of a very low-fat, vegan diet on patients with
rheumatoid arthritis (RA). Design: Single-blind dietary intervention study. Subjects and study …

Outcome of patients with active ankylosing spondylitis after two years of therapy with etanercept: clinical and magnetic resonance imaging data

X Baraliakos, J Brandt, J Listing… - Arthritis Care & …, 2005 - Wiley Online Library
Objective To examine the long‐term outcome of patients with active ankylosing spondylitis
(AS) clinically and by magnetic resonance imaging (MRI) after continuous treatment with the …